Objectives:
- New dermatopathology conditions
- New stains
- Latest guidelines
Needs:
- New advances in dermatologic treatment
- New methods of diagnosis or treatment
- Development of new technology
- Advances in medical knowledge
References:
- Fernandez-Figueras MT, Puig L. “Dermatopathology update.” Actax Dermoisfiliogr. 2013 Apr;104(3):204-11. doi: 10.1016/j.ad.2012.10.006. Epub 2012 Dec 25.
- Shalin Sara, Ferringer Tammie, Cassarino David S. “PAS and GMS utility in dermatopathology: Review of the current medical literature.” JCP. Nov 2020;47(11):1096-1102. doi: 10.1111/cup.13769
Core Competencies: 2, 3, 6, 7
Bio:
Dr. Amy Spizuoco is a board certified dermatologist and dermatopathologist. She did her undergraduate training at SUNY Binghamton, majoring in Italian and Biology. She then went to medical school at the NY College of Osteopathic Medicine.
After medical school, she completed her dermatology residency at LECOM/Alta Dermatology in Arizona. During that time she studied skin cancer surgery, pediatric dermatology at Phoenix Children’s Hospital and attended Dermatology Grand Rounds at Mayo Clinic in Scottsdale.
After residency, Dr. Spizuoco went back to NY to complete a dermatopathology fellowship at the Ackerman Academy of Dermatopathology.
Dr. Spizuoco has been practicing medical, surgical and cosmetic dermatology, as well as dermatopathology in Manhattan for 11 years.
She is the President elect of the American Osteopathic College of Dermatology and is an Associate Clinical Instructor in the Department of Dermatology at The Icahn School of Medicine at Mount Sinai Hospital.
Disclosure:
Consultant: Incyte
Speaker: Amgen, Almirall, Ortho-Derm, Regeneron, Galderma, Vyne